Kindly find the attached Voting Result of the Extra Ordinary General Meeting held on 04-04-2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dipna Pharmachem held its EGM on April 4, 2025 via video conferencing, which lasted only 9 minutes (3:00 PM to 3:09 PM). Three resolutions were put to vote and all three passed with overwhelming support, with approximately 99.91% votes in favour (6,431,000 out of 6,437,000 polled). The resolutions were: (1) Increase in Authorised Share Capital and alteration of the Capital clause in the Memorandum of Association (Ordinary), (2) Appointment of Mr. Nirav M Soni (DIN: 08317653) as Non-Executive and Non-Independent Director (Ordinary), and (3) Issue of Warrants convertible into Equity shares to persons/entities belonging to the Promoter/Promoter Group and Non-Promoter categories on a preferential basis (Special). Only about 26.77% of total outstanding shares (6,437,000 out of 24,045,250) were voted, with just 6,000 votes against across all resolutions.
Shareholders should note the preferential warrant issue (Resolution 3) will lead to equity dilution once warrants are exercised, potentially affecting shareholding percentage. The authorised share capital increase is a necessary step to facilitate this preferential allotment. The new director addition modestly expands the board.